baber/WOPTO huggingface dataset:
Patent FI-852060-L (FI)
Inventor: BIGGIO ALAIN
IPC: H01R4/24
Filed: 1985-05-23
Abstract: A device for the automatic and momentary electrical connection of the wires of a cable with the circuit of a memory. A sensor connects each wire of the cable with a telescopic tip and an electronic chip which connects the telescopic tips to a memory. As a button provided on the cover of the sensor is depressed, the telescopic tips pierce through a protecting film on the face of the electronic chip and provide electrical contact between the cable and the memory. The sensor and electronic chip each have a bevel gear, the teeth of which position the sensor relative to the electronic chip so that each engages an electrical contact on the surface of the electronic chip. An electronic circuit connected with the cable senses the angular position of each of the telescopic tips with reference to the electrical contacts. This device provides a momentary electrical contact with the electronic chip to read a memory or store data therein.
Patent FI-852987-L (FI)
Inventor: BERNHEIM MICHAEL
IPC: C07C69/86
Filed: 1985-08-02
Abstract: 1. A process for sizing paper or cardboard, which comprises using at least (A) a sizing agent consisting of an aromatic compound which contains in the aromatic nucleus a single hydrophobic substituent having at least 5 carbon atoms and at least one anionic group, acidic or in salt form, the hydrophobic substituent being linked to the aromatic nucleus through an ester, amide, urethane or urea bridge member, in the case of ester and amide bridge members the CO unit being attached to the hydrophobic radical and a methylene group being optionally present between the bridge members and the aromatic nucleus, and (B) a polymeric cationic retention aid.
Patent IE-41289-L (IE)
Title: Telecommunication repeater unit
IPC: H01P1/00
Filed: 1975-05-05
Abstract: A line device for transmission lines having coaxial cables for the transmission of signals, in particular digital signals or analog signals, employs an input equalizer in the form of a line section connected in parallel or in series to the transmission path, a first switch or dividing network for dividing the transmission path into a communications transmission path and a long distance current supply path, a regenerator in the communication transmission path, a series circuit connected in the long distance supply path including a first low pass filter, an element for producing a voltage drop for the current supply of the regenerator and a second low pass filter. A second switch or dividing network rejoins the communications and long distance supply paths and an output equalizer in the form of an additional line section is connected in parallel to the transmission path or in series with the transmission path. The line sections have at least two sub-sections of different wave resistances and at least one of the sections is adjustable during the manufacturing process in respect of its wave resistance. A terminating resistance is provided for each line section.
[US3980973A]
Patent IE-801082-L (IE)
Title: Production of building board
IPC: B28B5/02
Filed: 1980-05-23
Abstract: A building board comprises a core 31 of set cementitious material, such as gypsum, faced on at least one side by a fabric or web 33 of mineral fibres embedded in the face of the core and a continuous film 32 of the cementitious material having a higher density and lower porosity than the core extending over the outer face of the fabric. The film may have a smooth surface or a desired textured or figured surface. The preferred fabric or web 33 is a non-woven glass fibre tissue and it is preferred that a continuous film 32 of gypsum at the surface should not exceed 2 mm in thickness. The board is made by bringing the fabric or web into contact with the respective face of a layer of an aqueous slurry of gypsum plaster or other cementitious material, and vibrating the layer of slurry in contact with the fabric or web until slurry penetrates the web and the latter is completely embedded. The process can be carried out continuously by supporting the slurry between flexible belts which are vibrated by mechanical action applied to their faces remote from the slurry. Boards accordingly to the invenion can have greater strength and/or greater resistance to fire than conventional paper-faced gypsum board.
[US4378405A]
Patent IE-841137-L (IE)
Title: Pyrimidines
IPC: C07D235/14
Filed: 1984-05-08
Abstract: 1-(4-Pyrimidinyloxy)-3-(hetarylalkylamino)-2-propanols are cardiovascular agents having a range of vasodilator and adrenergic beta-receptor blocking activities making these compounds useful anti-hypertensive agents. Preferred compounds bear a hydrazino or hydrazono substituent in the 2- position of the pyrimidine ring.
[US4517188A]
Patent IE-891184-L (IE)
Title: Switched-capacitor circuit with large time constant
IPC: G11C27/02
Filed: 1989-04-11
Abstract: A switched capacitor circuit with a very large time constant. Numerous low frequency analog applications, modems for example, require this type of circuit. The capacitances required to obtain a sufficiently large time constant are reduced over prior art techniques by as much as 50%. The circuit is insensitive to parasitic capacitances. The circuit comprises a switched input sampling capacitor, an operational amplifier and a first feedback capacitor connected in parallel with the amplifier. The switched sampling capacitor samples an input signal in a first clock phase. A second feedback capacitor is switched during the first phase to sample the output of the operational amplifier; and, in a second phase, it is switched in parallel with the first feedback capacitor of the amplifier.
[US4894620A]
Patent IE-41092-L (IE)
Title: Refuse collection
IPC: B65F5/00
Filed: 1974-06-25
Abstract: A device for collecting materials in bulk inside a tank, preferably a rotating tank, comprising a discoid element rotatably mounted on the inner wall adjacent the charging mouth, and provided with a plurality of ribs or ridges destined to contact the material introduced into the tank, so as to facilitate the filling of the tank and to reduce appreciably the friction between the contacting parts.
[US3990590A]
Patent IE-36979-L (IE)
Title: Isolation of orgotein from red blood cells
IPC: A61K38/45
Filed: 1972-12-04
Abstract: 1386453 Orgotein DIAGNOSTIC DATA Inc 6 Dec 1972 [7 Dec 1971] 56243/72 Heading C3H A process for the isolation of orgotein from red blood cells involves subjecting a mixture of buffer-soluble red blood cell proteins which mixture contains at least orgotein, haemoglobin and carbonic anhydrase, to a chromatographic separation by (a) contacting the mixture of buffer-soluble proteins as an aqueous solution having an ionic strength of less than 0À01 M with an ion exchange resin having weakly basic groups, thereby adsorbing the orgotein on the resin (b) washing the ion exchange resin free of haemoglobin (c) eluting the adsorbed orgotein from the resin with an aqueous medium having a higher ionic strength and at a pH of approximately 6 and (d) separating orgotein from the fraction of the eluate having a peak divalent metal content (copper and zinc). Substantially pure orgotein is typically eluated at ionic strengths in the range 0À02-0À035 M. The isolated orgotein may be further purified by gel filtration or other conventional techniques. The preferred ion exchange resins are tertiary or quaternary amino-celluloses or -dextrans (specified). The starting mixture may be obtained from bovine, rabbit, monkey, rat, chicken or human red blood cells.
[GB1386453A]
Patent IE-892032-L (IE)
Title: Mini-proinsulin, its preparation and use
IPC: C07K19/00
Filed: 1989-06-22
Abstract: A mini-proinsulin in which the A and B chains are linked by the amino acid Arg in place of the C chain has insulin activity and is suitable for producing medicaments for the treatment of diabetes mellitus. It can also be converted straightforwardly with trypsin into an insulin derivative whose B chain is extended by Arg. The latter can be converted with carboxypeptidase B into insulin. However, it is also possible and advantageous to convert the mini-proinsulin directly into insulin in a one-pot process.
Patent IE-862067-L (IE)
Title: 2, 5-dkg reductase dna
IPC: C12P7/60
Filed: 1986-08-01
Abstract: PCT No. PCT/US86/01571 Sec. 371 Date Jun. 2, 1987 Sec. 102(e) Date Jun. 2, 1987 PCT Filed Aug. 1, 1986 PCT Pub. No. WO87/00863 PCT Pub. Date Feb. 12, 1987.An enzyme for conversion of 2,5-diketo-D-gluconate (2,5-DKG) to 2-keto-L-gulonic acid (2-KLG) and a genetically modified organism that expresses all the fermentation enzymes needed to convert glucose to 2-KLG (a precursor to ascorbic acid) using the new enzyme are described. Preferably, the organism is Erwinia citreus, or a mutated strain of Erwinia citreus, unable to use 2,5-DKG or 2-KLG as a sole carbon source, into which the gene for a 2,5-DKG reductase, produced by Corynebacterium sp., SHS 752001, has been inserted. The preferred transformed organism expresses the fermentation enzymes Erwinia citreus normally expresses for fermentation of glucose to 2,5-DKG and, in addition, an enzyme Corynebacterium sp. SHS 752001 expresses for fermentation of 2,5-DKG to 2-KLG.
[US4945052A]
Patent IE-42016-L (IE)
Title: Emulsion polymerisation of vinyl chloride
IPC: C08F259/04
Filed: 1975-09-23
Abstract: Method of preparing a stable latex having two substantially monodisperse populations of vinyl chloride polymer particles, which method comprises polymerizing, in aqueous emulsion, vinyl-polymerizable monomers containing at least 60% by weight vinyl chloride, in the presence of both A. A VINYL CHLORIDE POLYMER SEED LATEX PROVIDING BETWEEN ABOUT 0.5 AND 20% OF DRY SOLIDS BASED ON TOTAL WEIGHT OF SAID MONOMERS, HAVING PARTICLES OF MEAN DIAMETER BETWEEN ABOUT 0.15 AND 0.6 MICRONS AND HAVING A "FIRST" SURFACTANT IN AMOUNT CORRESPONDING TO A SEED-PARTICLE SURFACE COVERAGE OF FROM 5% TO 100%, AND B. A "SECOND" SURFACTANT OF DIFFERENT CHEMICAL TYPE IN AMOUNT CORRESPONDING TO FROM ABOUT 0.01% TO 2% BY WEIGHT OF TOTAL MONOMER, WHEREIN THE CHEMICAL TYPE OF EACH SURFACTANT IS NONIONIC OR CARBOXYLATE OR SULFONATE OR SULFATE OR SULFOSUCCINATE, BUT WHEREIN THE CHEMICAL TYPE OF THE "SECOND" SURFACTANT IS DIFFERENT FROM THE CHEMICAL TYPE OF THE "FIRST" SURFACTANT.
[US4046730A]
Patent IE-45973-L (IE)
Title: Vertical slat blind
IPC: E06B/
Filed: 1977-10-27
Abstract: The vertical lamellae can be rotated about their axes by means of a rotating device. This rotating device consists of an axially toothed driver shaft (1) and, situated in the trolley (2), a circle-segment-shaped crown gear (3') on a crown-gear shaft (3) which is positioned obliquely in relation to the lamella shaft. The trolleys (2) can be displaced along a support strip (not shown) and can, as a result of the oblique position of the crown-gear shaft (3), be pushed close against one another. The lamella is supported by the crown-gear shaft (3). <IMAGE>
[GB1589830A]
Patent IE-38639-L (IE)
Title: Texturing yarns
IPC: D02G1/16
Filed: 1973-12-13
Abstract: A method and apparatus to automatically adjust baffle setting for variations in processing conditions when using a yarn treating fluid jet having a baffle adjacent its outlet end. The baffle is mounted for free movement toward and away from the outlet end of the jet and defines with the adjacent outlet end surface of the jet a mutually shared area greater than the cross-sectional area of the exit of the treatment channel of the jet. The baffle is mounted at a position of equilibrium with respect to the fluid flow rate from the jet and can automatically adjust for minor changes in flow rate to maintain uniform operability.
[US3835510A]
Patent IE-45993-L (IE)
Title: Immunotherapy of neoplastic disease.
IPC: A61K39/00
Filed: 1977-11-23
Abstract: A process for producing a vaccine for use in the immunotherapy of neoplastic disease, said vaccine being produced by: (a) obtaining an amount of cancerous tissue from the patient to be treated; (b) disaggregating the tissue into its component cells: (c) suspending the cells in water; (d) subjecting the suspended cells to hydrodynamic turbulence sufficient to disrupt the cells and detach therefrom the cell components possessing cancer-specific antigens; and (e) contacting and admixing the cell components obtained in step (d) with a source of mangenous ion and a macro-molecular polysaccharide carbohydrate to form the vaccine. [IN146800A1]
Patent IE-46105-L (IE)
Title: Oxazolidinedione derivatives of vinca alkaloids.
IPC: A61K31/475
Filed: 1977-12-05
Abstract: 3-Spiro-5''-oxazolidine-2'',4''-dione derivatives of Vinca alkaloids, useful as anti-tumor agents and as intermediates.
[US4096148A]
Patent IE-842519-L (IE)
Title: Pyrrolidinones.
IPC: C07D207/26
Filed: 1984-10-03
Abstract: Compounds of the formula <IMAGE> wherein R1 is hydrogen or alkyl of 1 to 4 carbon atoms; R2 is 2-, 3- or 4-pyridyl, phenyl or mono- or di- substituted phenyl, where the substituents are each individually alkoxy of 1 to 2 carbon atoms, fluorine, chlorine, bromine, trifluoromethyl, alkyl or 1 to 4 carbon atoms, hydroxyl or nitro; and R3 and R4 are each independently hydrogen or alkyl of 1 to 4 carbon atoms; or R3 and R4, together with each other and the nitrogen atom to which they are attached, form an unsubstituted or methyl-substituted, saturated 5- or 6-membered heterocycle which may contain an additional oxygen or nitrogen heteroatom, or form an imidazole ring; where the aminomethyl substituent is attached to the 4- or 5-position or the pyrrolidine ring, and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as the salts are useful as nootropics and antihypoxics.
[US4767759A]
Patent IE-863082-L (IE)
Title: Production of n-formyl-ó-l-aspartyl-l-phenylalanine methyl¹ester
IPC: C07K5/075
Filed: 1986-11-21
Abstract: PURPOSE:To obtain the titled compound useful as a sweetener, in high yield, by reacting N-formyl-L-aspartic acid anhydride with L-phenylalanine methyl ester in a reaction solvent in the presence of acetic acid, etc., using a completely mixed continuous reaction process. CONSTITUTION:The objective compound is produced by reacting (A) N-formyl-L- aspartic acid anhydride with (B) L-phenylalanine methyl ester in a reaction solvent in the presence of acetic acid or acetic acid and formic acid [the amount of formic acid is preferably <=30(wt)% of acetic acid and <=5% of reaction solvent) preferably at <=80 deg.C usually in a residence time of <=6hr using a completely mixed continuous reaction process. The amount of acetic acid is preferably 10-150% of the reaction solvent. For example, an acetic acid-toluene solution of the compound B having a concentration of 0.1-0.8M/L is continuously supplied with the compound A and is made to react in a completely mixed state under agitation and the reaction liquid is continuously overflowed and extracted from the system.
[JP62149699A]
Patent IE-813102-L (IE)
Title: 1,2 dichloroethane
IPC: B01J23/78
Filed: 1981-12-31
Abstract: An oxychlorination catalyst contains a copper compound, magnesium oxide and aluminium oxide, and the copper compound is present as a distinct phase on a support in which at least part of the magnesium oxide is in combined form with alumina.
[US4451683A]
Patent IE-873386-L (IE)
Title: Preparation of thienylethylamines and dithienylethylamines
IPC: C07D333/20
Filed: 1987-12-14
Abstract: The invention has as its subject a process for the preparation of thienylethylamines of the formula R-NR-R' where R represents the group   <IMAGE>   and R' represents hydrogen or a group identical to R, by catalytic hydrogenation of a compound of the formula   <IMAGE> synthesis intermediates.
Patent NO-854371-L (NO)
Title: Herder for aminoplast, samt anvendelse av en slik herder.
Inventor: PITTEROFF WALTER
IPC: C08L5/00
Filed: 1985-11-01
Abstract: Herder for aminoplast, inneholdende uorganiske eller organiske syrer, stoffer som forårsaker tiksotropi i vandig miljø, (u)foretrede oligoglykoler og fuktemidler. i Anvendelse av herderen for utherding av iaminoplast som finner anvendelse ved kasjering av trematerialer med folie i henhold til valse-varmkasjeringsmetoden eller ved korttaktsbelegning av trematerialer med trefinér, som klebemiddel,. så vel som fremgangsmåter for valse-varmkasjering av trematerialer med folie og for korttaktsbelegning av trematerialer med trefinér.
Patent NO-863632-L (NO)
Inventor: SCHOLZ MATTHEW THOMAS
IPC: A61L15/48
Filed: 1986-09-11
Abstract: A curable resin coated sheet useful as an orthopedic bandage which has reduced tack is provided. The resin coated sheet is pre-lubricated with a lubricant which is a) bonded to the resin, b) added to the resin or applied to the surface of the coated sheet, or c) a combination of a) and b). The lubricant is present in an amount to reduce the kinetic coefficient of friction of a surface of the coated sheet to less than 1.2.
Patent NO-863833-L (NO)
Inventor: PFOHL SIGBERG
IPC: D21H17/36
Filed: 1986-09-25
Abstract: Water-soluble copolymers containing copolymerized vinylamine units are prepared by copolymerizing (a) from 95 to 10 mol % of N-vinylformamide and (b) from 5 to 90 mol % of an ethylenically unsaturated monomer from the group consisting of vinyl acetate, vinyl propionate, C1-C4-alkyl vinyl ethers, the esters, nitriles and amides of acrylic acid and methacrylic acid and N-vinylpyrrolidone, and then eliminating from 30 to 100 mol % of the formyl groups from the copolymer. Preferred copolymers are copolymers of N-vinylformamide and vinyl acetate, in which from 30 to 100 mol % of the monomer units are hydrolyzed. The copolymers are used in papermaking to increase the dry strength and wet strength of the paper.
Patent NO-873823-L (NO)
Inventor: NEWKIRK MARC S
IPC: C04B35/65
Filed: 1987-09-14
Abstract: A method of producing self-supporting ceramic bodies (12) having a polymer component, which includes first providing a self-supporting ceramic body (12) comprising (i) a polycrystalline oxidation reaction product formed upon oxidation of a molten parent metal with an oxidant, and (ii) interconnected porosity (13) at least partially accessible from one or more surfaces of said ceramic body. The polymer is disposed or formed within the interconnected porosity (13). The polymer is situated so as to alter, modify or contribute to the properties of the ceramic body (12) originally formed.
Patent NO-874796-L (NO)
Inventor: LINSLEY PETER S
IPC: C07K14/005
Filed: 1987-11-18
Abstract: Novel hybridoma cell lines producing monoclonal antibodies reactive with purified mucin antigens from normal and tumor sources are generated using mucins, including purified mucins from tumor sources. Epitopes on mucin antigens from normal and tumor sources are demonstrated to be distinct, using these new antibodies. The antibodies may be useful alone or in combination, in the diagnosis and treatment of cancer including malignancies of the breast and lung.
Patent NO-885312-L (NO)
Inventor: NODDIN RICHARD A
IPC: A61M25/00
Filed: 1988-11-29
Abstract: An inflatable medical balloon is formed by fabricating a tubular preform having a tapered region at the end of the portion where the main body of the balloon will form to enable the corresponding transition section of the blown balloon to have a separately controllable thickness profile. The preferred method includes providing a tube of a selected resin of wall thickness and diameter suitable for being formed into a balloon, and selectively heating to drawing temperature a defined region of the tube at one or both ends of the portion of the tube from which the balloon is to be formed. Tension is applied in opposite directions to respective ends of the heated region to draw the region to a smaller diameter, thereby providing a preform having, at the end of the portion of the tube, a tapered, relatively small diameter region of material that has substantially no crystallization or molecular orientation. In preferred embodiments a tapered region is provided at both ends of the portion in which the main body of the balloon is to be formed. Thereafter the tubular preform is heated to blowing temperature and, while heated, a balloon is formed by drawing and blowing the preform including the tapered regions. The balloon is mounted to form a balloon catheter device. A dilatation balloon catheter, is also described having wall thickness in the transition region less than 0.001 inch.
Patent NO-893438-L (NO)
Inventor: ANDERSSON THORBJOERN
IPC: B65D85/72
Filed: 1989-08-28
Abstract: Packing containers and packing container blanks of the type used for the packaging of e.g. milk and juice often are of the so-called gable-top type, the top closure also serving as an opening arrangement with a pouring spout which can be folded out. The parts (9, 10) forming the pouring spout (14) may be coated partly with a seal-preventing substance so as to make it possible for the pouring spout to be detached and let out in spite of the heat-sealing of the top. The seal-preventing coating (15) in accordance with the invention is covered by a film (16) which extends along the upper edge region of the packing container (1), which provides a better defined sealing strength, a tighter top seal, and protects the said coating (15) both before and after the conversion of the packing container blank (2) to packing containers (1)
Patent NO-901415-L (NO)
Inventor: FAURE JEAN-FRANCOIS
IPC: C22F1/00
Filed: 1990-03-28
Abstract: Al-based alloys of the 7000 series which have a high modulus (E >/= 74 GPa), a high mechanical strength (R0.2 >/= 530 MPa in the lengthwise direction), a good tenacity (KIC, lengthwise direction > 20 MPa  2ROOT m) and a good corrosion resistance under (O pressure >/= 250 MPa in the short transverse direction, lifetime >/= 30 days - ASTM Standard G 38-73). 
<??>The alloy according to the invention corresponds to the following weight composition:
 from 5.5 to 8.45% of Zr
 from 2 to 3.5% Mg
 from 0.5 to 2.5% Cu
 up to 0.5% Fe
 up to 0.5% Si
 other elements </= 0.05% each
 and up to 0.15% in all
 with
 0.1 </= Zr </= 0.5%
 0.3 </= Cr </= 0.6%
 0.3 </= Mn </= 1.1%
 
<??>It is preferably produced by the following process:
 a) a massive body which has the composition claimed above is formed by spray-deposition,
 b) this body is converted into a wrought product between 300 and 450 DEG C and then optionally when cold
 c) the wrought product is heat-treated by dissolving, quenching and annealing to a T6 or T7 state. 
<IMAGE>
Patent NO-903183-L (NO)
Inventor: SHROOT BRAHAM
IPC: A61K8/00
Filed: 1990-07-17
Abstract: Diaromatic esters. 
<??>The esters correspond to the formula: 
<IMAGE>
 in which : R1 denotes H, OH, -CH3, -CH2OH, -CH(OH)CH3, -COOR9, 
<IMAGE>
 or SO2R10, R9 denotes H, C1-C6 alkyl or a mono- or polyhydroxyalkyl radical, R10 denoting OH, C1-C6 or 
<IMAGE>
 r' and r" denoting H, C1-C6 alkyl, aryl, aralkyl, mono- or polyhydroxyalkyl, or r' and r" taken together form a heterocyclic ring, R2 denoting H, C1-C6 alkyl, OR9, F or -CF3, R3, R4 and R5 denote H, F, OH, -CH3, -OCH3, -CF3, -COOH or -CH2OH, R6 and R8 denote H,  alpha -substituted C3-C15 alkyl,  alpha , alpha '-disubstituted C4-C12 alkyl, C3-C12 cycloalkyl, mono- or polycyclic C5-C12 cycloalkyl in which the connecting carbon is trisubstituted, -SR11, -SO2R11 or -SOR11, R11 denoting C1-C6 alkyl or cycloalkyl, R6 and R8 being unable to denote simultaneously H, R7 denotes H, C1-C6 alkyl, alkenyl, alkenyloxy, OR12 or SR13, R12 denoting H, C1-C6 alkyl or alkenyl, R13 denoting H, C1-C6 alkyl or aralkyl, provided that when R1 denotes -CH2OH, -CH(OH)CH3, -COOR9 or 
<IMAGE>
 and R2 denotes H then: (i) either R3 and R4 are other than H or -CH3, (ii) or R7 is other than the radical OR12 and R6 or R8 is cycloalkyl > C7, (iii) or R7 denotes OR12, but R6 and R8 are then other than H, (iv) or R7 denotes OR12, but then R5 is other than H. 
<??>Use in human and veterinary medicine and in cosmetics.